Covaxin is not just safe among children 2-18 yrs old but produces 1.7 times greater antibodies, Lancet study
Read Time: < 1 minuteAccording to a recent study published in the peer-reviewed journal, The Lancet, Bharat Biotech's Covaxin has been found safe and immunogenic among the 2-18 year children…